Skip to the shortlist
Peptide ClarityGuide

Your shortlist for energy

By Peptide Clarity Guide · October 2026

Compare services that list NAD+ and related treatments: clinician access, pharmacy information, recurring costs and cancellation terms. Inclusion describes the service criteria; it does not establish that a treatment improves energy. Persistent fatigue deserves medical evaluation before choosing a wellness product.

All the energy providers, In first, then Not yet.

We may earn a commission through qualifying provider links at no extra cost to you. Read our selection criteria and funding disclosure. How we earn

Partners on this list

Partner cards: if you join through one, the provider pays us a fee and your price stays the same. The full list below keeps its pick order.

Made the shortlist

Listed in pick order. See how picks work.

  1. Top pick

    NAD+ as a nasal spray, face cream, patch or shot, each with its own plan.

    NAD+ cream$95/mo
    Visit AgelessRx
  2. Separate NAD+ injection and nasal plans show their selected recurring charges.

    NAD+ nasal spray$134/mo
    Visit HealthRX
  3. NAD+ as an injection or a daily troche, with no membership fee to join.

    NAD+ injections$249/mo
    Visit PauseRx
  4. NAD+ shots at one month-to-month price that covers the visit, follow-up and shipping.

    NAD+ injections$129/mo
    Visit Brightmeds
  5. Gala GLP-1Partner

    NAD+ has a stated written-review pathway; confirm the full charge schedule.

    NAD+ injectionsPrice on request
    Visit Gala GLP-1
  6. NAD+ has separate injection, nasal and oral listings; confirm the exact charge schedule.

    NAD+ injectionsPrice on request
    Visit Lttl
  7. NAD+ injection has a starting monthly offer; it does not establish energy benefits.

    NAD+ injections$199/mo
    Visit Willow

Not a pick yet

  • Arc-1 Not yet

    Why: Prints no cancellation terms for its monthly subscriptions.

    When the gap closes, Arc-1 can move to In.

    Read the pick
  • Bayan Health Not yet

    Why: Investigational peptide listings leave the qualifying access pathway unclear.

    When the gap closes, Bayan Health can move to In.

    Read the pick
  • BioGlow Health Not yet

    Why: Approximate month-supply prices do not establish automatic refill charges or dates.

    When the gap closes, BioGlow Health can move to In.

    Read the pick
  • bmiMD Not yet

    Why: Terms describe twenty-eight-to-thirty-day renewal and separate quarterly billing.

    When the gap closes, bmiMD can move to In.

    Read the pick
  • Bodybuilding Health+ Not yet

    Why: Lists Strive Pharmacy but not which Strive site fills your order.

    When the gap closes, Bodybuilding Health+ can move to In.

    Read the pick
  • DirectMeds Not yet

    Why: Its BPC-157 listing does not meet the reviewed routine commercial compounding conditions.

    When the gap closes, DirectMeds can move to In.

    Read the pick
  • Eden Not yet

    Why: GLP-1 no-membership claims differ from recurring-membership terms.

    When the gap closes, Eden can move to In.

    Read the pick
  • EdgeRx Not yet

    Why: Names Strive Pharmacy as its one pharmacy, but not which Strive site ships.

    When the gap closes, EdgeRx can move to In.

    Read the pick
  • ElitePhysiqMD Not yet

    Why: Its investigational peptide catalog leaves the qualifying access pathway unclear.

    When the gap closes, ElitePhysiqMD can move to In.

    Read the pick
  • ElleS Not yet

    Why: The actual dispensing site and selected payment and refund agreement need confirmation.

    When the gap closes, ElleS can move to In.

    Read the pick
  • Embody Not yet

    Why: Confirm the current renewal amount and charge interval before comparing plans.

    When the gap closes, Embody can move to In.

    Read the pick
  • Enhance MD Not yet

    Why: Its partner lists differ; confirm the actual dispensing pharmacy and site.

    When the gap closes, Enhance MD can move to In.

    Read the pick
  • Fridays Not yet

    Why: TRT medication is extra; GLP-1 promotional totals need a selected renewal quote.

    When the gap closes, Fridays can move to In.

    Read the pick
  • KIN Meds Not yet

    Why: Starting hormone offers do not settle the selected form, testing and recurring total.

    When the gap closes, KIN Meds can move to In.

    Read the pick
  • Live Vital Not yet

    Why: Its peptide menu does not meet the reviewed routine commercial compounding conditions.

    When the gap closes, Live Vital can move to In.

    Read the pick
  • MangoRx Not yet

    Why: The TRT testing offer and laboratory costs leave the full medication renewal unclear.

    When the gap closes, MangoRx can move to In.

    Read the pick
  • Next Vial Not yet

    Why: Starting offers and differing GLP-1 pages leave selected renewal charges unconfirmed.

    When the gap closes, Next Vial can move to In.

    Read the pick
  • Nova Not yet

    Why: Prescribing-decline fees and medication and membership charges need clarification.

    When the gap closes, Nova can move to In.

    Read the pick
  • Oak Not yet

    Why: Lists tesamorelin without saying whether it's the brand drug or compounded.

    When the gap closes, Oak can move to In.

    Read the pick
  • PeterMD Not yet

    Why: Confirm the dispensing facility, current authorization and actual recurring agreement.

    When the gap closes, PeterMD can move to In.

    Read the pick
  • RNK Health Not yet

    Why: Inclusive-price claims differ from terms allowing separate pharmacy fees.

    When the gap closes, RNK Health can move to In.

    Read the pick
  • Science & Co Not yet

    Why: Annual headlines do not establish the selected ongoing invoice and charge interval.

    When the gap closes, Science & Co can move to In.

    Read the pick
  • SkinnyRx Not yet

    Why: Current introductory GLP-1 offers do not establish the later renewal charge.

    When the gap closes, SkinnyRx can move to In.

    Read the pick
  • Sprout Health Not yet

    Why: Four-week product renewal differs from monthly policy and legacy payment instructions.

    When the gap closes, Sprout Health can move to In.

    Read the pick
  • System Labs Not yet

    Why: Homepage and product offers differ; crossed-out figures do not establish renewal.

    When the gap closes, System Labs can move to In.

    Read the pick
  • Wellorithm Not yet

    Why: Monthly pricing and twenty-eight-day terms describe different renewal schedules.

    When the gap closes, Wellorithm can move to In.

    Read the pick
  • WePeptideRx Not yet

    Why: Dose-selector prices differ from the same product page’s overview.

    When the gap closes, WePeptideRx can move to In.

    Read the pick

What the rules check, and what to expect

Getting In takes six things. Someone licensed reads your intake before a vial ships. You see the monthly cost before you type a card number. A licensed US pharmacy does the compounding, and the store sells no research-use peptides. Cancel terms are posted, and the signup really opens. How picks work has the exact wording.

Now the honest part. NAD+ participates in cellular energy metabolism, but that mechanism does not establish a benefit from an injected product. FDA’s interim compounding policy is conditional. No controlled wellness evidence establishing improved energy from these home injections was identified. Start with what NAD+ is, then how long NAD+ shots take to work and at-home shots versus an IV drip.

How to choose between the picks

  • Start with the fatigue assessment. Tell the clinician when the tiredness began and how it affects ordinary activities. Ask whether the assessment investigates that complaint or simply screens eligibility for a wellness prescription. Those are different services even when both use an online questionnaire. Establish what findings would lead to another evaluation instead of an NAD+ order. A treatment menu cannot identify the cause of your fatigue.
  • Ask what the proposed route actually demonstrates. An IV study, a home injection and a nasal preparation involve different exposure questions. A blood marker moving in one setting does not establish that another formulation improves daily energy. Request the study population and measured outcome behind the proposed claim. Also ask whether the preparation offered to you matches that research. Convenience can inform a preference without proving equivalent benefit.
  • Translate the vial offer into your invoice. Record the prescribed quantity, shipment frequency and amount collected at renewal. A vial described as a month of supply does not establish when another payment will occur. Include any consultation or membership that continues between shipments. The calculator can annualize a confirmed fixed-day charge using a 365-day basis. Actual payments during your enrollment depend on their dates and your stopping point.
  • Agree on a meaningful reassessment. Ask which change in daily functioning would justify continuing the proposed care. A testimonial or a laboratory marker alone cannot establish that your fatigue improved because of NAD+. Clarify when the clinician will revisit the decision and what happens if you notice no benefit. Find out whether that conversation is included or separately charged. Buying a longer supply should not replace the reassessment.

Questions about this list

How much does NAD+ cost a month?
Selected current examples include Brightmeds at $129 monthly and HealthRX at $161 for a one-month injection plan. Confirm prescribed quantity and included services; the cost guide separates vial and prepaid offers.
Will NAD+ injections give me more energy?
Nobody can promise that. Controlled evidence has not established improved energy from the commercial at-home NAD+ injections. Testimonials cannot establish benefit. Discuss the cause of fatigue, alternatives and meaningful monitoring with your clinician.
Why do glutathione and sermorelin count toward the energy list?
People hunting for more energy ask about both, so a provider that sells either one can appear here. NAD+ is still the main reason this list exists, and each compound has its own guide on what the studies show.
Is NAD+ FDA-approved?
No. Injectable NAD+ is a compounded prescription. FDA’s Category 1 listing is under evaluation and its interim policy has conditions. A prescription and pharmacy license do not by themselves approve a finished preparation.

This is general information, not medical advice. A licensed clinician can tell you what fits you. Health note